March 20, 2023

 

 

 

VIA EDGAR

 

U.S. Securities and Exchange Commission

Division of Corporation Finance,

100 F Street, N.E.

Washington, D.C. 20549-3628

 

Attention:		Josh Gorsky and Joe McCann
Re:		Apexigen, Inc. Registration Statement on Form S-1 File No. 333-269912

Acceleration Request

 

Requested Date: March 21, 2023

Requested Time: 4:05 p.m. Eastern Time,

or as soon thereafter as practicable

 

 

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Apexigen, Inc. (the “Company”) hereby requests that the above-referenced Registration Statement on Form S-1 (File No. 333-269912) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission.

Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Wilson Sonsini Goodrich & Rosati, Professional Corporation, by calling Lance Brady at (650) 565-3836.

Please direct any questions or comments regarding this acceleration request to Lance Brady at (650) 565-3836.

 

[Signature page follows]

 

 

 

 

 

 

---

 

Sincerely,

Apexigen, Inc.

 

/s/ Xiaodong Yang

Xiaodong Yang, M.D., Ph.D.

Chief Executive Officer

 

 

 

cc:	Francis Sarena, Apexigen, Inc. Michael E. Coke, Wilson Sonsini Goodrich & Rosati, Professional Corporation Lance Brady, Wilson Sonsini Goodrich & Rosati, Professional Corporation

 

 

---